“I have worked with Ozgun side by side as part of same organization for 3.5 years. Ozgun has always impressed me with his great communication skills. He is a team player and easy going person. His abilities help his team’s team building efforts. He is structured in his thinking and has a special gift to analyze complex processes, situations and describe it. He successfully analyzed need for sample management process throughout Pfizer Emerging Markets by communicating with every team member from each country, consolidating the need, analyzing the situation and proposing an offering. He has strong analytical skills and will not be satisfied by delivering what is requested from him. He will go into the details of the need, will have extensive research on the topic and will come up with ideas that would add value to business and shape the end result. It was a pleasure to work together with him to come up with a video sharing platform offering that would be used widely in Pfizer.”
About
Activity
-
Since the war broke out in Ukraine, I couldn't return to my routine of learning something new every day. A few weeks ago, I decided to regain my…
Since the war broke out in Ukraine, I couldn't return to my routine of learning something new every day. A few weeks ago, I decided to regain my…
Liked by Ozgun (Oz) Demir
Experience & Education
Licenses & Certifications
Publications
-
Hype or hope? New e-book tackles artificial intelligence in pharma and healthcare
Fierce Pharma
“As marketers have more data available to target the most relevant audience, the shared benefit is that pharmaceutical companies and brands will be able to better target their messaging to the right customer audience, at the right time, with the right channel mix," Ozgun Demir, director of digital strategy at Novartis Oncology and an Intouch client, said in an emailed statement.
-
Bayer blazes new trails for pharma with Betaseron Facebook ad
Fierce Pharma
Bayer uses Facebook's targeting to reach people on the platform who are interested in MS-related information, Demir said. The end result? A 96% decrease in costs per lead. It also increases the number of leads, so much so that it has at times overwhelmed the nursing staff, he said.
Courses
-
Gamification - University of Pennsylvania
-
-
Introduction to Breast Cancer - Yale University
-
-
The Science of Well Being - Yale University
-
Projects
-
Flexible Working Vision
-
Company Engagement Team
-
Investigated the factors behind colleagues' motivations and came up with suggestions to increase engagement company wide.
Honors & Awards
-
2024 MM&M 40 Under 40
MM&M
40 Under 40 program has turned the spotlight on the abundance of young creatives, strategists and media people set to lead the medical marketing business into the decades ahead.
-
2020 PM360 ELITE
PM360
Digital Crusaders: Those who advance digital channel applications or platforms to transform marketing and/or company operations.
-
2018 MM&M Top 40 Healthcare Transformer
MM&M
Over the course of the past decade, Demir has been equal parts visionary and cheerleader for health tech efforts. Prior to his Novartis tenure, Demir created a host of online marketing campaigns for Bayer and Pfizer all around the world, including tough-to-break and often neglected markets such as the Middle East and Africa.
For Bayer, Demir led a successful effort to add social media to the company's hematology marketing playbook. Speaking at Digital Pharma East, he discussed the…Over the course of the past decade, Demir has been equal parts visionary and cheerleader for health tech efforts. Prior to his Novartis tenure, Demir created a host of online marketing campaigns for Bayer and Pfizer all around the world, including tough-to-break and often neglected markets such as the Middle East and Africa.
For Bayer, Demir led a successful effort to add social media to the company's hematology marketing playbook. Speaking at Digital Pharma East, he discussed the thought and planning that went into the first Facebook ad with scrolling important safety information, which included a call now button for Betaseron, a drug used to treat symptoms of relapsing multiple sclerosis.
However, his advocacy of all things health tech is no less notable. Demir was one of the first high-level execs to push for the adoption of new, boundary-pushing tactics both publicly and zealously. To that end, he has served as a guest lecturer at Brown University to explore the use of artificial intelligence as well as data mining and analytics in healthcare.
Test Scores
-
Toefl
Score: 114
-
ALES
Score: 93
Languages
-
English
Full professional proficiency
-
Italian
Professional working proficiency
-
Turkish
Native or bilingual proficiency
-
Spanish
Elementary proficiency
-
German
Elementary proficiency
Recommendations received
7 people have recommended Ozgun (Oz)
Join now to viewOther similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More